Fingolimod

Description :

Fingolimod is a novel immune modulator that prolongs allograft transplant survival in numerous models by inhibiting lymphocyte emigration from lymphoid organs.
Additional Information:
Delivery Time: 1 to 2 days after PO and payment
Packaging Details: 25 kg paking
Generic Name: Fingolimod
Brand Name: Gilenya
Drug Class: Sphingosine 1-phosphate receptor modulator
Route of Administration: Oral
Forms: Capsules (typically 0.5 mg)
Relapsing-Remitting Multiple Sclerosis (RRMS): To reduce the frequency of relapses and delay the progression of disability in patients with RRMS.
Secondary Progressive Multiple Sclerosis (SPMS): In some cases, fingolimod may be used to treat SPMS with active disease.
Fingolimod was one of the first oral disease-modifying therapies approved for MS, providing a significant advancement over previous treatments that required injectable administration. I